Finance

Lists
COHANCE:NSE
Cohance Lifesciences Ltd
464,70 INR
+1,03%
(+4,75) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for COHANCE...
Open
460,45 INR
High
467,35 INR
Low
458,10 INR
Mkt. cap
177,79 მლრ.
Avg. vol.
1,08 მლნ.
Volume
763,45 ათ.
P/E ratio
167,81
52-wk high
917,85 INR
52-wk low
266,70 INR
EPS
2,77 INR
No. of employees
3 ათ.
Open
460,45 INR
High
467,35 INR
Low
458,10 INR
Mkt. cap
177,79 მლრ.
Avg. vol.
1,08 მლნ.
Volume
763,45 ათ.
P/E ratio
167,81
52-wk high
917,85 INR
52-wk low
266,70 INR
EPS
2,77 INR
No. of employees
3 ათ.
News stories
From web sources and news partners
About Cohance Lifesciences Ltd
CEO-
Employees2,81 ათ.
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitecohance.com
Last report
5 აგვ. 2026
Fiscal period
Q1 2027
-0,63 INR / 1,00 INR
-163,00%miss
Revenue / Est. (INR)
4,22 მლრდ. / 5,00 მლრდ.
-15,61%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,56 მლრდ.
5,45 მლრდ.
6,19 მლრდ.
4,22 მლრდ.
Cost of goods sold
1,41 მლრდ.
1,59 მლრდ.
3,56 მლრდ.
1,20 მლრდ.
Cost of revenue
1,41 მლრდ.
1,59 მლრდ.
3,56 მლრდ.
1,20 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,27 მლრდ.
1,19 მლრდ.
1,47 მლრდ.
1,33 მლრდ.
Operating expense
3,38 მლრდ.
3,37 მლრდ.
2,14 მლრდ.
3,50 მლრდ.
Total operating expenses
4,79 მლრდ.
4,96 მლრდ.
5,70 მლრდ.
4,71 მლრდ.
Operating income
769,30 მლნ.
484,10 მლნ.
491,10 მლნ.
-483,80 მლნ.
Other non operating income
156,00 მლნ.
61,60 მლნ.
-310,30 მლნ.
122,50 მლნ.
EBT including unusual items
837,70 მლნ.
406,00 მლნ.
199,10 მლნ.
-428,70 მლნ.
EBT excluding unusual items
837,70 მლნ.
454,60 მლნ.
171,40 მლნ.
-428,70 მლნ.
Income tax expense
173,80 მლნ.
115,80 მლნ.
116,00 მლნ.
23,20 მლნ.
Effective tax rate
20,75%
28,52%
58,26%
-5,41%
Other operating expenses
1,67 მლრდ.
1,72 მლრდ.
152,80 მლნ.
1,68 მლრდ.
Net income
740,80 მლნ.
367,20 მლნ.
195,50 მლნ.
-241,20 მლნ.
Net profit margin
13,33%
6,74%
3,16%
-5,71%
Earnings per share
1,93
0,55
0,68
-0,63
Interest and investment income
-
-
27,30 მლნ.
-
Interest expense
-87,60 მლნ.
-91,10 მლნ.
-91,90 მლნ.
-67,40 მლნ.
Net interest expenses
-87,60 მლნ.
-91,10 მლნ.
-64,60 მლნ.
-67,40 მლნ.
Depreciation and amortization charges
440,20 მლნ.
469,40 მლნ.
512,30 მლნ.
495,40 მლნ.
EBITDA
1,23 მლრდ.
677,82 მლნ.
865,38 მლნ.
-15,48 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები